Westfield Capital Management
RLAY icon

Westfield Capital Management’s Relay Therapeutics RLAY Stock Holding History

Westfield Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.6M Buy
+3,343,496
New +$48.5M 0.2% 136

Other funds holding RLAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Westfield Capital Management's RLAY Position: Q2 2026 in Review

Westfield Capital Management opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 3,343,496 shares worth $62.6M. The stake represents 0.2% of the portfolio and ranks #136 among its holdings.

162 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Westfield Capital Management held 3,343,496 shares of Relay Therapeutics worth $62.6M as of Q2 2026.
  • Relay Therapeutics was a new Westfield Capital Management position in Q2 2026.
  • Relay Therapeutics made up 0.2% of Westfield Capital Management's portfolio in Q2 2026, its #136 holding.
  • 162 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.